Body: One of the most promising avenues in anti-aging research involves targeting senescent cells – “zombie cells” that accumulate with age and contribute to inflammation and tissue dysfunction. Senolytics are drugs designed to selectively kill these harmful cells, while senomorphics aim to alter their behavior. Early research shows remarkable results in animal models, extending lifespan and improving healthspan. This article explores the science behind senolytics and senomorphics, discussing their potential to rejuvenate tissues, alleviate age-related diseases, and usher in a new era of regenerative medicine.
